Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;10(11):1022-3.
doi: 10.1016/S1470-2045(09)70253-0. Epub 2009 Sep 18.

Risk estimation for the next generation of prevention programmes for cervical cancer

Hormuzd A Katki  1 , Sholom Wacholder, Diane Solomon, Philip E Castle, Mark Schiffman
Affiliations

Risk estimation for the next generation of prevention programmes for cervical cancer

Hormuzd A Katki et al. Lancet Oncol. 2009 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None of the authors has a personal financial conflict of interest to report. The authors’ financial holdings and activities are reviewed annually for potential conflicts of interest by the National Institutes of Health Ethics Program. The National Cancer Institute has a clinical trials agreement with GlaxoSmithKline (Rixensart, Belgium) in which we are autonomously assessing their bivalent prophylactic HPV vaccine. The company will be provided the data as part of their efficacy demonstration, while we will independently analyse and publish the findings. The bulk of funding for this large trial, apart from the provision of vaccine and components required for the vaccine’s regulatory approval, is provided by the National Cancer Institute.

References

    1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907. - PubMed
    1. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346–355. - PubMed
    1. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197:340–345. - PubMed
    1. Bulkmans NWJ, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJP, Bulk S, Voorhorst FJ, Verheijen RHM, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJF, Meijer CJLM. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007;370:1764–1772. - PubMed
    1. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929–936. - PubMed